PD60-05 NEOADJUVANT CHEMOTHERAPY PLUS RADICAL CYSTECTOMY VERSUS RADICAL CYSTECTOMY ALONE IN CLINICAL T2 BLADDER CANCER PATIENTS WITHOUT HYDRONEPHROSIS: RESULTS FROM A LARGE MULTICENTER COHORT STUDY

Autor:	Wassim Kassouf, John S. McGrath, Bas W.G. van Rhijn, Jay B. Shah, Marc A. Dall'Era, Andrew J. Stephenson, Shahrokh F. Shariat, Petros Grivas, Srikala S. Sridhar, Paolo Gontero, Philippe E. Spiess, Yair Lotan, Andrew C. Thorpe, Trinity J. Bivalacqua, Adrian Fairey, Jonathan L. Wright, Evan Y. Yu, Michael S. Cookson, Scott North, Todd M. Morgan, Jeffrey M. Holzbeierlein, Francesco Soria, Peter C. Black, Daniel A. Barocas
Rok vydání:	2020
Předmět:	Cisplatin Chemotherapy medicine.medical_specialty Bladder cancer business.industry Urology medicine.medical_treatment medicine.disease Cystectomy medicine business Hydronephrosis medicine.drug Cohort study
Zdroj:	Journal of Urology. 203
ISSN:	1527-3792 0022-5347
Popis:	INTRODUCTION AND OBJECTIVE:Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is the standard and recommended treatment for clinical T2-T4aN0M0 bladder cancer. Howev...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d1f17a51abc3b11ad2368ef8a4a7f262 https://doi.org/10.1097/ju.0000000000000977.05 Zobrazit plný text záznamu